ICER chastises J&J for overpricing depression drug esketamine 'where there is such need for treatment' - Endpoints News

Submitted by Anonymous (not verified) on Fri, 05/10/2019 - 11:05

ICER chastises J&J for overpricing depression drug esketamine 'where there is such need for treatment'  Endpoints NewsCognizant of the myriad of approved antidepressants that often don't work, regulators endorsed J&J's $JNJ pharmaceutical version of the hallucinogenic ...